MEDGENICS INC's ticker is MDGN and the CUSIP is 58436Q203. A total of 53 filers reported holding MEDGENICS INC in Q3 2015. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $111,000 | 0.0% | 20,000 | 0.0% | 0.05% | 0.0% |
| Q2 2016 | $111,000 | +26.1% | 20,000 | 0.0% | 0.05% | +23.7% |
| Q1 2016 | $88,000 | -26.7% | 20,000 | 0.0% | 0.04% | -28.3% |
| Q4 2015 | $120,000 | -23.1% | 20,000 | 0.0% | 0.05% | -26.4% |
| Q3 2015 | $156,000 | +26.8% | 20,000 | 0.0% | 0.07% | +35.8% |
| Q2 2015 | $123,000 | -23.6% | 20,000 | 0.0% | 0.05% | -18.5% |
| Q1 2015 | $161,000 | +59.4% | 20,000 | 0.0% | 0.06% | +91.2% |
| Q4 2014 | $101,000 | -2.9% | 20,000 | 0.0% | 0.03% | -2.9% |
| Q3 2014 | $104,000 | -66.5% | 20,000 | -50.0% | 0.04% | -38.6% |
| Q2 2014 | $310,000 | +10.7% | 40,000 | 0.0% | 0.06% | +14.0% |
| Q1 2014 | $280,000 | +16.7% | 40,000 | 0.0% | 0.05% | +13.6% |
| Q4 2013 | $240,000 | -23.1% | 40,000 | 0.0% | 0.04% | -21.4% |
| Q3 2013 | $312,000 | +36.8% | 40,000 | -33.3% | 0.06% | +100.0% |
| Q2 2013 | $228,000 | – | 60,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,058,400 | $8,277,000 | 4.07% |
| Belmont Global Advisors, Inc. | 155,000 | $1,212,000 | 2.06% |
| Broadfin Capital, LLC | 1,545,306 | $12,084,000 | 0.67% |
| CARL DOMINO INC | 34,134 | $267,000 | 0.21% |
| QVT Financial LP | 267,608 | $2,093,000 | 0.07% |
| WHITE PINE CAPITAL LLC | 20,000 | $156,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 119,000 | $931,000 | 0.02% |
| HYMAN CHARLES D | 13,000 | $102,000 | 0.02% |
| Kavar Capital Partners, LLC | 1,500 | $11,000 | 0.01% |
| Brick & Kyle, Associates | 1,000 | $8,000 | 0.01% |